Biomarker research

Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important.

Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer. 

The idea of taking a small vial of blood and being able to detect cancer at its earliest and most treatable stages is an attractive one.

We speak to our scientists who are developing urine tests that aim to detect bladder and pancreatic cancer earlier.

Inflammation can prevent infections and helps repair injuries. But for people with long-term inflammatory conditions, it can sometimes lead to cancer.

Our scientists have uncovered a new marker that’s found on treatment-resistant prostate cancer cells.

Our scientists have found that breast cancer is not 1 but 10 different diseases, each with a different risk of coming back or spreading.

We’re looking into a certain type of cancer that is diagnosed once it has already spread, and doctors can’t find where the cancer first started growing.

Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening.

A ’10 minute cancer test’ is big news today. But while science behind the headlines is exciting, but it’s a long way from being used to diagnose cancer.